4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0000899140-25-001459
Director bought 46,141 shares at an average $11.68 ($538,972)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-18 | Purchase | +8,700 | $11.24 | $97,788 | 9,546,875 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-18 | Purchase | +1,515 | $11.24 | $17,029 | 1,821,327 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-19 | Purchase | +13,950 | $11.48 | $160,146 | 9,560,825 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-19 | Purchase | +2,434 | $11.48 | $27,942 | 1,823,761 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-22 | Purchase | +16,650 | $12.08 | $201,132 | 9,577,475 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-22 | Purchase | +2,892 | $12.08 | $34,935 | 1,826,653 | I |
| Open-market purchases · 46,141 sh · avg $11.68 · $538,972 | |||||||
Loading xslF345X05/form4.xml…